Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Tan, Emily L.C.; Ooi, Eng Eong; Lin, Chin-Yo; Tan, Hwee Cheng; Ling, Ai Ee; Lim, Bing; Stanton, Lawrence W.

Search our Collections

Back to Previous Page

- Add this to...

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Published Date:

Apr 2004

Source:

Emerg Infect Dis. 10(4):581-586.

[PDF-131.59 KB]

Details:

Alternative Title:

Emerg Infect Dis

Personal Author:

Tan, Emily L.C. ; Ooi, Eng Eong ; Lin, Chin-Yo ; Tan, Hwee Cheng ; Ling, Ai Ee ; ... More ▼

Description:

Severe acute respiratory syndrome (SARS) is an infectious disease caused by a newly identified human coronavirus (SARS-CoV). Currently, no effective drug exists to treat SARS-CoV infection. In this study, we investigated whether a panel of commercially available antiviral drugs exhibit in vitro anti-SARS-CoV activity. A drug-screening assay that scores for virus-induced cytopathic effects on cultured cells was used. Tested were 19 clinically approved compounds from several major antiviral pharmacologic classes: nucleoside analogs, interferons, protease inhibitors, reverse transcriptase inhibitors, and neuraminidase inhibitors. Complete inhibition of cytopathic effects of SARS-CoV in culture was observed for interferon subtypes, b-1b, a-n1, a-n3, and human leukocyte interferon a. These findings support clinical testing of approved interferons for the treatment of SARS.

Subject:

[+]

Document Type:

Journal Article

Collection(s):

Emerging Infectious Diseases

Main Document Checksum:

[+]

File Type:

Supporting Files:

	03-0458-F1.gif	image/gif
	03-0458-F1.jpg	image/jpeg
	03-0458-F2.gif	image/gif
	03-0458-F2.jpg	image/jpeg
	03-0458.nxml	text/plain
	license.txt	text/plain

No Related Documents.

Inhibition of SARS Coronavirus Infection In Vitro with Clinically Approved Antiviral Drugs

Search our Collections

You May Also Like:

Have Questions?

CDC INFORMATION

CONNECT WITH CDC